We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase 1 and 2 Study of PX-866 and Cetuximab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01252628
Recruitment Status : Completed
First Posted : December 3, 2010
Last Update Posted : May 16, 2018
Information provided by (Responsible Party):
Seagen Inc. ( Cascadian Therapeutics Inc. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : November 2013
Actual Study Completion Date : January 2014
Certification/Extension First Submitted : April 30, 2015